Archives for

Big Pharma

Divergent stances on key issues could spark clash between Trump and Ryan

Jim Stinson, House Speaker Paul Ryan was in Janesville, Wisconsin, on Monday when he got a phone call from the media. The reporter asked about President-Elect Donald Trump’s views on NATO, which he called obsolete. It was the kind of rhetoric used to distract voters while no real change happened along the borders, or in

H.S. Students Recreate $750 Medication For Only $2

Fiona Miller | Students defeat crony Big Pharma profit model. Martin Shkreli, otherwise known as Pharma Bro, made headlines last year when he upped the price of the HIV drug Daraprim by almost 4,000% in a day. Knowing this drug was necessary to save many people’s lives, it appeared Shkreli had done this for

Big Pharma’s Crusade Against Rural America

Mytheos Holt,  The fight between the corporatist drug industry and hospitals serving the most vulnerable Americans has finally spilled into the mainstream media. Recently, the Washington Post covered the issue in a profile of former Democratic congressman Henry Waxman. Waxman is surely an unlikely hero to fight corporate welfare, yet according to the Post, that’s

Weaponizing the Term œConspiracy Theory: Disinformation Agents and the CIA

Global Research – by Dr. Gary G. Kohls Conspiracy theory’ is a term that strikes fear and anxiety in the hearts of most every public figure, particularly journalists and academics. Since the 1960s the label has become a disciplinary device that has been overwhelmingly effective in defining certain events as off limits to inquiry or

Big Big Pharma: Pfizer raises bid for AstraZeneca to $117 billion

 U.S. drugmaker Pfizer said on Sunday it had raised its offer for British rival AstraZeneca to 69.3 billion pounds ($116.6 billion), or 55 pounds a share, and would walk away if AstraZeneca did not accept it. Pfizer wants to create the world’s largest drugs company, with a headquarters in New York but a tax base

Big Pharma: Pfizer Planning to Raise AstraZeneca Bid Above $106 Billion

Pfizer Inc. (PFE) is preparing to sweeten its bid for AstraZeneca Plc (AZN) to more than 63 billion pounds ($106 billion) in an attempt to lure the U.K.’s second-biggest drugmaker to the negotiating table, people with knowledge of the matter said. The offer may value AstraZeneca at more than 50 pounds a share and include